R, D., & H, T. (2022). Symptomatic melanoma CNS metastases in the TRICOTEL study - Authors' reply. The Lancet. Oncology, 23(11), e482. https://doi.org/10.1016/S1470-2045(22)00647-7
Chicago Style (17th ed.) CitationR, Dummer, and Tawbi H. "Symptomatic Melanoma CNS Metastases in the TRICOTEL Study - Authors' Reply." The Lancet. Oncology 23, no. 11 (2022): e482. https://doi.org/10.1016/S1470-2045(22)00647-7.
MLA (9th ed.) CitationR, Dummer, and Tawbi H. "Symptomatic Melanoma CNS Metastases in the TRICOTEL Study - Authors' Reply." The Lancet. Oncology, vol. 23, no. 11, 2022, p. e482, https://doi.org/10.1016/S1470-2045(22)00647-7.
Warning: These citations may not always be 100% accurate.